Aram Zabeti

Aram Zabeti

Associate Professor and Division Director for Multiple Sclerosis

One Stetson Square

2320

COM Neurology and Rehabilitation - 0525

Stetson Building
Cincinnati, Ohio 45219

Professional Summary

Associate Professor of Neurology 
Director and Endowed Chair 
Waddell Center for Multiple Sclerosis

Education

Medical Degree, Azad University School of Medicine 1999

Residency, West Virginia University School of Medicine 2012 (Neurology)

Fellowship, Oregon Health and Science University 2013 (Multiple Sclerosis)

Research and Practice Interests

Multiple Sclerosis
MS Specialist

UC Health Clinical Focus

Neurology

UC Health Specialities

Neurology

Certifications

American Board of Psychiatry and Neurology (Neurology)

09/20/2012

Research Support

Grant: #Medical Student Research Scholarship (Marcucci) Investigators:Marcucci, Samuel; Zabeti, Aram 06-02-2018 -06-01-2019 Foundation of the Consortium of Multiple Sclerosis Centers The Effect of Ocrelizumab on Lymphocytes in Multiple Sclerosis Patients Previously Exposed to Lymphocyte Depleting Agents Role:PI $5,000.00 Active Level:Private Non-Profit

Grant: #CCF / MS-1610-37047MS-1610-37047 Investigators:Zabeti, Aram 02-01-2018 -01-31-2023 Patient-Centered Outcomes Research Institute DELIVER-MS Role:PI $278,505.00 Awarded Level:Private Non-Profit

Grant: #FY20ITN345 / UM1AI109565 Investigators:Gul, Zartash; Zabeti, Aram 02-01-2020 -01-31-2021 National Institute of Allergy and Infectious Diseases Immune Tolerance Network - BEAT-MS Role:PI $485,483.00 Awarded Level:Federal

Publications

Peer Reviewed Publications

Kitsou, Efstathia; Pan, Sheng; Zhang, Jianpeng; Shi, Min; Zabeti, Aram; Dickson, Dennis W; Albin, Roger; Gearing, Marla; Kashima, Daniel T; Wang, Yan; Beyer, Richard P; Zhou, Yong; Pan, Catherine; Caudle, W Michael; Zhang, Jing (2008. )Identification of proteins in human substantia nigra.Proteomics. Clinical applications, ,2 (5 ),776-82

Costa-Mallen, Paola; Checkoway, Harvey; Zabeti, Aram; Edenfield, Michael J; Swanson, Phillip D; Longstreth, W T; Franklin, Gary M; Smith-Weller, Terri; Sadrzadeh, Sayed M H (2008. )The functional polymorphism of the hemoglobin-binding protein haptoglobin influences susceptibility to idiopathic Parkinson's disease.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, ,147B (2 ),216-22

Obeidat, Ahmed Z; Jacob, Cara; Zabeti, Aram (2017. )Concurrent Dawson's Fingers and Area Postrema Lesion in a Mixed Neuroimmune Disorder.The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, ,44 (4 ),452-454

Fox, Robert J; Coffey, Christopher S; Cudkowicz, Merit E; Gleason, Trevis; Goodman, Andrew; Klawiter, Eric C; Matsuda, Kazuko; McGovern, Michelle; Conwit, Robin; Naismith, Robert; Ashokkumar, Akshata; Bermel, Robert; Ecklund, Dixie; Koepp, Maxine; Long, Jeffrey; Natarajan, Sneha; Ramachandran, Srividya; Skaramagas, Thomai; Thornell, Brenda; Yankey, Jon; Agius, Mark; Bashir, Khurram; Cohen, Bruce; Coyle, Patricia; Delgado, Silvia; Dewitt, Dana; Flores, Angela; Giesser, Barbara; Goldman, Myla; Jubelt, Burk; Lava, Neil; Lynch, Sharon; Miravalle, Augusto; Moses, Harold; Ontaneda, Daniel; Perumal, Jai; Racke, Michael; Repovic, Pavle; Riley, Claire; Severson, Christopher; Shinnar, Shlomo; Suski, Valerie; Weinstock-Gutman, Bianca; Yadav, Vijayshree; Zabeti, Aram (2016. )Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.Contemporary clinical trials, ,50 ,166-77

Van Sanford, Carson; Obeidat, Ahmed Z; Hagen, Matthew; Zabeti, Aram (2019. )A case of fatal invasive aspergillosis in a patient with neurosarcoidosis treated with infliximab.The International journal of neuroscience, ,129 (6 ),619-622

Fox, Robert J; Coffey, Christopher S; Conwit, Robin; Cudkowicz, Merit E; Gleason, Trevis; Goodman, Andrew; Klawiter, Eric C; Matsuda, Kazuko; McGovern, Michelle; Naismith, Robert T; Ashokkumar, Akshata; Barnes, Janel; Ecklund, Dixie; Klingner, Elizabeth; Koepp, Maxine; Long, Jeffrey D; Natarajan, Sneha; Thornell, Brenda; Yankey, Jon; Bermel, Robert A; Debbins, Josef P; Huang, Xuemei; Jagodnik, Patricia; Lowe, Mark J; Nakamura, Kunio; Narayanan, Sridar; Sakaie, Ken E; Thoomukuntla, Bhaskar; Zhou, Xiaopeng; Krieger, Stephen; Alvarez, Enrique; Apperson, Michelle; Bashir, Khurram; Cohen, Bruce A; Coyle, Patricia K; Delgado, Silvia; Dewitt, L Dana; Flores, Angela; Giesser, Barbara S; Goldman, Myla D; Jubelt, Burk; Lava, Neil; Lynch, Sharon G; Moses, Harold; Ontaneda, Daniel; Perumal, Jai S; Racke, Michael; Repovic, Pavle; Riley, Claire S; Severson, Christopher; Shinnar, Shlomo; Suski, Valerie; Weinstock-Guttman, Bianca; Yadav, Vijayshree; Zabeti, Aram (2018. )Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.The New England journal of medicine, ,379 (9 ),846-855

Contact Information

Academic - Stetson Building
Cincinnati  Ohio, 45219
Phone: 513-558-0192
aram.zabeti@uc.edu